Effectiveness of Conventional Disease-modifying Antirheumatic Drugs in Psoriatic Arthritis: A Systematic Review Jesús Maese, Petra Díaz del Campo, Daniel Seoane-Mato, Mercedes Guerra, Juan D. Cañete

Tocilizumab in Patients With Active Rheumatoid Arthritis and Inadequate Response to Disease-modifying Antirheumatic Drugs or Tumor Necrosis Factor Inhibitors: Subanalysis of Spanish Results of an Open-label Study Close to Clinical Practice José M. Álvaro-Gracia, Antonio Fernández-Nebro, Alicia García-López, Manuel Guzmán, Francisco J. Blanco, Francisco J. Navarro, Sagrario Bustabad, Yolanda Armendáriz, José A. Román-Ivorra

Efficacy and Safety of Golimumab as Add-on Therapy to Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the GO-MORE Study in Spain Alberto Alonso, Carlos M. González, Javier Ballina, María L. García Vivar, Juan J. Gómez-Reino, Jose Luis Marenco, Antonio Fernández-Nebro, Carmen Ordás, Luis Cea-Calvo, María J. Arteaga, Raimon Sanmartí